1959
DOI: 10.1246/bcsj.32.883
|View full text |Cite
|
Sign up to set email alerts
|

Syntheses of Kinetin-analogues. II

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

1966
1966
2024
2024

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(4 citation statements)
references
References 3 publications
0
4
0
Order By: Relevance
“…Studies on the effect of aromatic substituents on the activity of b6Ade [20] provide support for this hypothesis. The activity of orthosubstituted derivatives of b6Ade depends on the nature of the substituent, ortho-OMe or CF3 Table 1 Torsion angles in degrees for the side chains of several cytokinins Molecule ¢~1 ¢/2 ~3 f6Ade 73 110 7 i6Ade 63 87 2 b6Ade 72 102 6 2MeSi6Ade 216 103 1 b6Ado 145 78 -6 f6Ado 57 106 12 substitution greatly diminishes cytokinin activity, while ortho-Cl substitution has only a small effect.…”
Section: Resultsmentioning
confidence: 81%
“…Studies on the effect of aromatic substituents on the activity of b6Ade [20] provide support for this hypothesis. The activity of orthosubstituted derivatives of b6Ade depends on the nature of the substituent, ortho-OMe or CF3 Table 1 Torsion angles in degrees for the side chains of several cytokinins Molecule ¢~1 ¢/2 ~3 f6Ade 73 110 7 i6Ade 63 87 2 b6Ade 72 102 6 2MeSi6Ade 216 103 1 b6Ado 145 78 -6 f6Ado 57 106 12 substitution greatly diminishes cytokinin activity, while ortho-Cl substitution has only a small effect.…”
Section: Resultsmentioning
confidence: 81%
“…C, 61.2; H, 5.1; N, 27.4%); TLC, single spot: HPLC: purity > 99%; m.p. 272–273°C (248–249°C according to Okomura et al 1959). 1 H‐NMR (DMSO‐d 6 , 300 MHz): days 3.70 (s, 3H, OCH3), 4.68 (bs, 2H, CH 2 Ph), 6.78 (dt, 1H, Ph), 6.91 (s, 1H, Ph), 6.93 (d, 1H, Ph), 7.20 (t, 1H, Ph), 8.13 (s, 1H, purine H (2)), 8.19 (s, 1H, purine H (8)), 12.92 (s, 1H, NH).…”
Section: Methodsmentioning
confidence: 99%
“…The exploration of cytokinins (CKs) dates back to 1955 when Miller et al [1] identified kinetin as the first cytokinin, recognizing its cell-division-promoting properties. Subsequently, in 1959, Okumura et al [2] synthesized a spectrum of kinetin analogues and BA (benzyladenine) derivatives. Their activities remained elusive for nearly three decades until Kaminek et al [3] unveiled the significant biological effects of topolins, in 1987.…”
Section: Introductionmentioning
confidence: 99%